POS-344 ASSOCIATION BETWEEN RELATIVE ESTIMATED GLOMERULAR FILTRATION RATE CHANGES AND CLINICAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES

• E. CAPLAN,
• R. Sheer,
• N. Schmedt,
• T. Evers,
• M. Cockrell,
• M. Tindall,
• M. Pasquale,
• C.P. Kovesdy

Affiliations

E. CAPLAN

Humana, Humana Healthcare Research, Louisville, United States

R. Sheer

Humana, Humana Healthcare Research, Louisville, United States

N. Schmedt

Bayer AG, Medical Affairs & Pharmacovigilance, Berlin, Germany

T. Evers

Bayer AG, Medical Affairs & Pharmacovigilance, Berlin, Germany

M. Cockrell

Humana, Retail Trend and Innovation, Louisville, United States

M. Tindall

Humana, Humana Pharmacy Solutions, Louisville, United States

M. Pasquale

Humana, Humana Healthcare Research, Louisville, United States

C.P. Kovesdy

University of Tennessee, Health Science Center, Memphis, United States